EV/EBITDA:
-11.74+0.02(+0.17%)Summary
- As of today (September 17, 2025), NAMS EV/EBITDA is -11.74, with a rise of +0.02 (+0.17%) during the most recent trading session on September 17, 2025.
- Over the past year, NAMS EV/EBITDA has dropped by -2.77 (-30.88%).
- NAMS EV/EBITDA is now -156.33% below its all-time high of -4.58.
Performance
NAMS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NAMS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.2% | -0.2% | -0.1% |
| 1 m1 month | +3.1% | -3.1% | -2.3% |
| 3 m3 months | -74.7% | +59.3% | +32.5% |
| 6 m6 months | -18.6% | +16.8% | +4.9% |
| ytdytd | -5.5% | +3.9% | -4.7% |
| 1 y1 year | -30.9% | +110.2% | +58.5% |
| 5 y5 years | - | - | - |
NAMS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -11.39 | -3.1% | -13.39 | +12.3% |
| 3 m | 3-month | -6.41 | -83.2% | -13.39 | +12.3% |
| 6 m | 6-month | -4.58 | -156.3% | -13.39 | +12.3% |
| 1 y | 1-year | -4.58 | -156.3% | -18.46 | +36.4% |
| 3 y | 3-year | -4.58 | -156.3% | -284.06 | +95.9% |
| 5 y | 5-year | -4.58 | -156.3% | -1189 | +99.0% |
| alltime | all time | -4.58 | -156.3% | -1189 | +99.0% |
NAMS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -11.74(+5.5%) |
| 2024 | -11.13(-93.6%) |
| Date | Value |
|---|---|
| 2022 | -174.80(+72.8%) |
| 2021 | -101.16 |
FAQ
- What is NewAmsterdam Pharma Company N.V. EV/EBITDA?
- What is the all time high EV/EBITDA for NewAmsterdam Pharma Company N.V.?
- What is NAMS EV/EBITDA year-to-date change?
- What is NewAmsterdam Pharma Company N.V. EV/EBITDA year-on-year change?
What is NewAmsterdam Pharma Company N.V. EV/EBITDA?
The current EV/EBITDA of NAMS is -11.74
What is the all time high EV/EBITDA for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high EV/EBITDA is -4.58
What is NAMS EV/EBITDA year-to-date change?
NewAmsterdam Pharma Company N.V. EV/EBITDA has changed by -0.61 (-5.48%) since the beginning of the year
What is NewAmsterdam Pharma Company N.V. EV/EBITDA year-on-year change?
Over the past year, NAMS EV/EBITDA has changed by -2.77 (-30.88%)